Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMISE Trial: Encapsulated FMT in Cirrhosis
NCT06461208Phase 3Recruiting
- Sponsor
- King's College London
- Start
- Jun 2023
- Primary completion
- Jan 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of fecal microbiome transplant in Liver cirrhosis (LC), sponsored by King's College London. Started Jun 2023; status: recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT06461208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06461208.